Zynerba Pharmaceuticals, Inc. Quarterly Operating Income (Loss) in USD from Q1 2014 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Zynerba Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2014 to Q2 2023.
  • Zynerba Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending June 30, 2023 was -$11.1M, a 21.5% decline year-over-year.
  • Zynerba Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending June 30, 2023 was -$38.8M, a 4.49% decline year-over-year.
  • Zynerba Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$35.3M, a 4.13% increase from 2021.
  • Zynerba Pharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was -$36.8M, a 29.4% increase from 2020.
  • Zynerba Pharmaceuticals, Inc. annual Operating Income (Loss) for 2020 was -$52.1M, a 51.7% decline from 2019.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 -$38.8M -$11.1M -$1.97M -21.5% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 -$36.8M -$10.5M -$1.57M -17.6% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q4 2022 -$35.3M -$8.69M +$150K +1.7% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-28
Q3 2022 -$35.4M -$8.49M +$1.72M +16.8% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-14
Q2 2022 -$37.1M -$9.17M +$670K +6.81% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$37.8M -$8.9M -$1.02M -12.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$36.8M -$8.84M +$1.35M +13.3% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-28
Q3 2021 -$38.1M -$10.2M -$979K -10.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$37.1M -$9.84M +$12M +55% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 -$49.1M -$7.88M +$2.91M +27% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 -$52.1M -$10.2M +$1.23M +10.7% Oct 1, 2020 Dec 31, 2020 10-K 2021-03-10
Q3 2020 -$53.3M -$9.23M -$7.31M -379% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$46M -$21.8M -$10.3M -89.7% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 -$35.7M -$10.8M -$1.33M -14.1% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q4 2019 -$34.3M -$11.4M -$3.37M -41.9% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-10
Q3 2019 -$30.9M -$1.93M +$6.06M +75.9% Jul 1, 2019 Sep 30, 2019 10-K 2021-03-10
Q2 2019 -$37M -$11.5M +$459K +3.83% Apr 1, 2019 Jun 30, 2019 10-K 2021-03-10
Q1 2019 -$37.5M -$9.47M +$2.93M +23.6% Jan 1, 2019 Mar 31, 2019 10-K 2021-03-10
Q4 2018 -$40.4M -$8.05M +$158K +1.93% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-10
Q3 2018 -$40.6M -$7.99M +$564K +6.6% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-10
Q2 2018 -$41.1M -$12M -$3.6M -43.1% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-10
Q1 2018 -$37.5M -$12.4M -$4.69M -60.9% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-10
Q4 2017 -$32.8M -$8.2M -$1.52M -22.7% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-11
Q3 2017 -$31.3M -$8.55M -$2.55M -42.6% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-11
Q2 2017 -$28.8M -$8.37M -$2.08M -33.1% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-11
Q1 2017 -$26.7M -$7.7M -$3.46M -81.6% Jan 1, 2017 Mar 31, 2017 10-K 2019-03-11
Q4 2016 -$23.2M -$6.68M -$1.27M -23.4% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-12
Q3 2016 -$21.9M -$6M -$2M -50.1% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-12
Q2 2016 -$19.9M -$6.28M -$4.66M -286% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-12
Q1 2016 -$15.3M -$4.24M -$2.75M -184% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-12
Q4 2015 -$12.5M -$5.42M -$4.01M -286% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-27
Q3 2015 -$8.52M -$4M -$1.48M -58.9% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-27
Q2 2015 -$7.04M -$1.63M -$118K -7.8% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-27
Q1 2015 -$6.92M -$1.49M -$1.25M -524% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-27
Q4 2014 -$5.67M -$1.4M Oct 1, 2014 Dec 31, 2014 10-K 2016-03-14
Q3 2014 -$2.51M Jul 1, 2014 Sep 30, 2014 10-K 2016-03-14
Q2 2014 -$1.51M Apr 1, 2014 Jun 30, 2014 10-K 2016-03-14
Q1 2014 -$239K Jan 1, 2014 Mar 31, 2014 10-K 2016-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.